A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1997
To compare the relative bioavailability of gabapentin 400 mg capsules (Purepac) with that of NEURONTIN® 400 mg capsules (Parke-Davis) in healthy adult male subjects under non-fasting conditions, and to compare the differences in plasma levels after dosing the test formulation with and without food
Epistemonikos ID: 46b37d9aeac48a5fb4cd8d246160cfb4130b53c7
First added on: May 05, 2024